bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
Select Page

bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

by Maria Zannes | Sep 19, 2023 | Press Releases

Transformative Strategic Transaction Supports Commercialization of CyPath® Lung Precision Pathology Founder Dr. Roby Joyce Joins bioAffinity’s Board of Directors Conference Call at 4:30 p.m. Eastern time Today SAN ANTONIO, Texas (Sept. 19, 2023) – bioAffinity...

bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference

by Maria Zannes | Sep 7, 2023 | Press Releases

SAN ANTONIO, Texas (Sept. 7, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, today announced that Maria Zannes, President and CEO, will present a corporate...

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update

by Maria Zannes | Aug 10, 2023 | Press Releases

SAN ANTONIO, Texas (Aug. 14, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three...

AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer

by Maria Zannes | Jul 12, 2023 | Press Releases

SAN ANTONIO, Texas (July 12, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, today announced that the American Medical Association (AMA) has released a...

bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium

by Maria Zannes | Jun 15, 2023 | Press Releases

SAN ANTONIO, Texas (June 15, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for early-stage cancer detection and broad-spectrum cancer therapeutics, will present the poster “Vitamin B12 deprivation does not...
« Older Entries

Categories

  • Articles (18)
  • Events (38)
  • News (43)
  • Press Releases (70)
  • Publications (16)

Recent Posts

  • bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services September 19, 2023
  • bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference September 7, 2023
  • bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update August 10, 2023
  • AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer July 12, 2023
  • bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium June 15, 2023

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
Copyright © 2023 bioAffinity Technologies, Inc.